February 12, 2014Asepsis announces the patent pending Momenta-Dose™Asepsis announces the patent pending Momenta-Dose™, a parenteral injection device designed to administer an injection solely by a user’s applied force and subsequent momentum. This autogenic momentum CONTINUE READING